Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Leads Strong Week for BCW Index

Shares of Molecular Devices rose 7.1 percent for the five-day trading period ended Tuesday, leading all firms in the BCW Index. All 15 companies in the Index gained ground for the week, though Bruker was the only other firm to eclipse a 5-percent rise for the period.
 
Overall, the Index rose 2.4 percent. In comparison, the Dow Jones Industrial Average and the Nasdaq each gained 1.6 percent for the same period. The Nasdaq Biotech Index was up 1.8 percent.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 5, 2006)
Last
Price
(November 28, 2006)
% change
Agilent A
33.16
32.60
1.7
Applied Biosystems ABI
37.82
36.32
4.1
Beckman BEC
60.55
59.00
2.6
Bio-Rad BIO
81.60
78.96
3.3
Bruker BRKR
8.00
7.59
5.4
GE GE
35.27
35.20
0.2
Invitrogen IVGN
56.90
55.45
2.6
Millipore MIL
69.89
67.95
2.9
Molecular Devices MDCC
22.20
20.72
7.1
PerkinElmer PKI
21.50
21.10
1.9
Qiagen QGEN
14.52
14.24
2.0
Sigma SIAL
77.01
75.96
1.4
Stratagene STGN
7.55
7.40
2.0
Thermo TMO
44.53
43.69
1.9
Waters WAT
49.82
49.43
0.8
BCW Index Average  
41.35
40.37
2.4
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.